IP Library › Patent Application 16434799
Patent Application
App. No. 16/434,799

COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/434,799
Abstract

Improved compositions and methods for treating muscular dystrophy by administering antisense molecules capable of binding to a selected target site in the human dystrophin gene to induce exon skipping are described.

Claims (1)

1 . A method for treating Duchenne muscular dystrophy in a patient in need thereof comprising administering to the patient a dose of eteplirsen of about 30 mg/kg once a week.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 16, 2022
From: BIOPHARMA CREDIT PLC
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 061120/0886 →
CORRECTIVE ASSIGNMENT TO CORRECT THE TYPOGRAPHICAL ERROR APP. NO 62/869,456 SHOULD BE CORRECTED AS 62/863,456 PREVIOUSLY RECORDED AT REEL: 051355 FRAME: 0280. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 9, 2020
From: SAREPTA THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 051554/0339 →
SECURITY INTEREST Recorded Dec 23, 2019
From: SAREPTA THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 051355/0280 →